Skip to main content
. 2019 Dec 18;10(1):4. doi: 10.3390/biom10010004

Figure 7.

Figure 7

Figure 7

(a) Experimental workflow to determine the interaction of antibody (trastuzumab) to silica-immobilized LPG. (b) QCM-D response for the binding interactions of trastuzumab to silica-immobilized LPG and subsequent detection of HER2 antigen spiked in 25% human serum. The arrows indicate the time points for the injection of LPG, trastuzumab, and HER2. (c) Frequency shifts for binding interactions between trastuzumab and HER2 spiked in various biological fluids. Extensive PBS washing was performed between each sample injection.